Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

Sarepta Therapeutics announced the grant of equity awards on Sept. 30, 2026, which were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, in accordance with Nasdaq Listing Rule 5635(c)(4).